Hydroxychloroquine-Induced Phospholipidosis - A Forgotten Complication of a Common Drug.
Indian J Nephrol
; 34(2): 175-177, 2024.
Article
en En
| MEDLINE
| ID: mdl-38681001
ABSTRACT
Hydroxychloroquine (HCQ) has immunomodulatory and immunosuppressive properties and is used in many rheumatological conditions like systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome. It is usually a widely used and well-tolerated DMARD (Disease Modifying Anti Rheumatic Drugs). Its most feared toxicities include retinopathy and, rarely, cardiomyopathy. Among its other reported side effects is drug-induced phospholipidosis. Here, we report two cases of HCQ-induced phospholipidosis based on renal biopsy electron microscopy. HCQ-induced phospholipidosis, although uncommon, must be considered as one of the differentials in a patient with persistent proteinuria.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Indian J Nephrol
Año:
2024
Tipo del documento:
Article
País de afiliación:
India
Pais de publicación:
India